Dolby Laboratories (DLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 03-2005 | 12-2004 | 09-2004 | 06-2004 | 03-2004 | |
| Sales | 85,101 | 84,263 | 289,041 | 76,050 | 78,691 |
| Cost of Goods | 23,715 | 26,976 | 91,505 | 23,198 | 24,753 |
| Gross Profit | 61,386 | 57,287 | 197,536 | 52,852 | 53,938 |
| Operating Expenses | 44,065 | 40,122 | 130,178 | 32,566 | 34,294 |
| Operating Income | 18,036 | 18,141 | 67,863 | 20,484 | 20,397 |
| Interest Expense | 0 | 0 | 2,348 | 0 | 0 |
| Other Income | 751 | 287 | 2,577 | 370 | 156 |
| Pre-tax Income | 18,787 | 18,428 | 68,092 | 20,854 | 20,553 |
| Income Tax | 8,000 | 7,743 | 27,321 | 8,392 | 8,124 |
| Net Income Continuous | 10,330 | 10,377 | 39,842 | 11,968 | 12,359 |
| Net Income | $10,330 | $10,377 | $39,842 | $11,968 | $12,359 |
| EPS Basic Total Ops | 0.11 | 0.12 | 0.47 | 0.14 | 0.14 |
| EPS Basic Continuous Ops | 0.11 | 0.12 | 0.47 | 0.14 | 0.14 |
| EPS Diluted Total Ops | 0.10 | 0.11 | 0.43 | 0.13 | 0.14 |
| EPS Diluted Continuous Ops | 0.10 | 0.11 | 0.43 | 0.13 | 0.14 |
| EBITDA(a) | $20,850 | $20,468 | $76,380 | $22,865 | $20,397 |